Intracerebroventricular injection of glucagon-like peptide-1 changes lipid metabolism in chicks

Comp Biochem Physiol A Mol Integr Physiol. 2007 Aug;147(4):1104-8. doi: 10.1016/j.cbpa.2007.03.023. Epub 2007 Mar 30.

Abstract

Glucagon-like peptide-1 (GLP-1), derived from proglucagon, is thought to act as a negative regulator of energy homeostasis in mammals, since intracerebroventricular (ICV) injection of GLP-1 inhibits feeding behavior and enhances energy expenditure. The anorexigenic effect of GLP-1 is also observed in chicks, but whether brain GLP-1 enhances energy expenditure has not been investigated. The aim of the present study was to clarify the effect of ICV injection of GLP-1 on energy expenditure as well as metabolic changes in chicks. The injection of GLP-1 did not affect energy expenditure calculated from oxygen consumption and carbon dioxide production. On the other hand, the injection of GLP-1 significantly decreased respiratory quotient, suggesting that brain GLP-1 shifted the use of energy sources from carbohydrates to lipids. In support of this, ICV injection of GLP-1 increased plasma non-esterified fatty acid concentration while plasma glucose concentration was decreased. In conclusion, GLP-1 appears to act in the brain as a metabolic modulator rather than as a regulator of total energy expenditure in chicks.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Glucose / analysis
  • Carbon Dioxide / metabolism
  • Chickens / metabolism*
  • Energy Metabolism / drug effects
  • Fatty Acids, Nonesterified / blood
  • Glucagon-Like Peptide 1 / administration & dosage*
  • Glucagon-Like Peptide 1 / pharmacology*
  • Injections, Intraventricular
  • Lipid Metabolism / drug effects*
  • Male
  • Oxygen Consumption / drug effects
  • Respiration / drug effects
  • Triglycerides / blood

Substances

  • Blood Glucose
  • Fatty Acids, Nonesterified
  • Triglycerides
  • Carbon Dioxide
  • Glucagon-Like Peptide 1